Skip to main content
Premium Trial:

Request an Annual Quote

Martina Bielefeld-Sevigny

Premium
PerkinElmer Life and Analytical Sciences announced this week the appointment of Martina Bielefeld-Sevigny as vice president and general manager of drug discovery and research reagents. 
 
Bielefeld-Sevigny most recently served as director of molecular pharmacology within PerkinElmer Bio-discovery's reagents business, and led the company's Center of Excellence in Montreal, Canada.
 
Prior to joining PerkinElmer in 2004, Bielefeld-Sevigny was the director of process development at DSM Biologics of Montreal. Before DSM Biologics, Bielefeld-Sevigny held a series of jobs at Pharmacia Biotech in Freiburg, Germany; Uppsala, Sweden; and Montreal.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.